APE1/Ref-1 in Alzheimer's disease: an immunohistochemical study

Neurosci Lett. 2009 Dec 11;466(3):124-7. doi: 10.1016/j.neulet.2009.09.039. Epub 2009 Sep 25.

Abstract

The oxidative injury in Alzheimer's disease (AD), in which amyloid beta protein induces production of reactive oxygen species, may be cause of neurodegeneration. APE1/Ref-1 is a protein involved in DNA repair and in redox co-activating function over different transcription factors. We investigated by immunohistochemistry using a highly specific monoclonal antibody, the localization of APE1/Ref-1 in autoptic and bioptic AD brain tissues in comparison with brains with unrelated pathological or normal conditions. Reliable APE1/Ref-1 immunostaining was obtained in biopsies, but not in autoptic tissues. An increased nuclear expression of APE1/Ref-1 in AD cerebral cortex supports the view that the cellular adaptive response to the oxidative stress condition is involved in the pathogenesis of this disease.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / metabolism*
  • Antibodies, Monoclonal
  • Autopsy
  • Biopsy
  • Brain / metabolism
  • DNA-(Apurinic or Apyrimidinic Site) Lyase / immunology
  • DNA-(Apurinic or Apyrimidinic Site) Lyase / metabolism*
  • Humans
  • Immunohistochemistry
  • Middle Aged

Substances

  • Antibodies, Monoclonal
  • APEX1 protein, human
  • DNA-(Apurinic or Apyrimidinic Site) Lyase